BioStem Technologies, Inc.

OTC: BSEM · Healthcare · Biotechnology

PublicHQ Fort Lauderdale, FL · BrowardCIK 0001658678Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 56

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, market scale · ↓ Piotroski F, filing timeliness

Methodology →

Revenue TTM

-$60.3M

Rev growth YoY (TTM)

-119.6%

Net income (FY)

—

Employees

as of 2026-08-19

Market cap

$53.5M

as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BioStem Technologies, Inc.’s financial profile?

BioStem Technologies, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Boundless Bio, Inc.——MindWalk Holdings Corp.——MiNK Therapeutics, Inc.——Apollomics, Inc.——Mach7 Technologies Limited——Vicapsys Life Sciences, Inc.——

Neighbors

Broward →

HEICO Corporation$4.5B84B+Chewy, Inc.$12.6B58C Element Solutions Inc$2.6B78B+AutoNation, Inc.$27.6B74B VSE Corporation$1.1B69B Willis Lease Finance Corporation$730.2M72B

Key facts

CEOJason Matuszewski

SectorHealthcare

IndustryBiotechnology

HeadquartersFort Lauderdale, FL

ExchangeOTC: BSEM

Employees73

IPO date2015-03-17

Latest filings

8-K2026-08-12 10-Q2026-08-12 8-K2026-08-07

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.